Based on 14 analysts giving stock ratings to Encompass Health Corp in the past month.
In the current month, EHC has received 8 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. EHC average Analyst price target in the last month is 147.800.
Based on analysts' estimates, EHC EPS is projected to reach 1.361 in FY2026Q3, following reported EPS of 1.554 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD 1.55, while Encompass Health CorpEHC's earnings per share (EPS) for the previous quarter was USD 1.96. EPS for the next quarter is expected at USD 1.36.